Angiosarcoma Awareness Inc has provided a $25k grant to the Broad Institute in order to obtain and ship living tumor samples from angiosarcoma patients to the Cancer Cell Line Factory
July 2, 2021
Each cancer center may only see a small handful of patients with a given rare tumor a year, making the collection of living tissue samples—at the scale required to create laboratory cell models to drive research—nearly impossible. To be able to develop the model derivation effort in this disease, the Cancer Cell Line Factory (CCLF), plans to […]
The Angiosarcoma Project in the News
September 30, 2018
The American Association for Cancer Research (AACR) issued the following press release focused on the Angiosarcoma Project, whose work is guided by Angiosarcoma Awareness, Inc.’s Vice President Dr. Corrie Painter. A Patient-partnered Genomics Study Identifies Immunotherapy as Potential Treatment for a Rare Cancer 9/30/2018 NEW YORK — Angiosarcoma Project, a patient-partnered genomics study, identified […]
New clinical trial is now recruiting in Boston
February 13, 2018
A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, check out the recently updated clinical trials page of our website, which is located under our Resources section.
Presenting the We Will Prevail 5K!
January 30, 2018
After taking a year off for a strategic re-brand, we are excited to unveil the return of our community’s beloved 5K event, revamped for its 7th year, in its new location in Herter Park in Boston, MA! Registration is NOW OPEN for the 2018 We Will Prevail 5K- Run, Walk, & Kids Race Benefiting Angiosarcoma […]
